Liam Scott

Company: Neumora

Job title: Senior Director, Translational Sciences

Seminars:

Panel Discussion: Assessing the Pros & Cons of Muscarinic PAMs vs. Agonists for Side Effect Alleviation & Efficacy Across Symptom Domains 4:30 pm

What are the main advantages and disadvantages of preclinically developing and clinically investigating a muscarinic receptor agonist compared to a PAM, and how are the disadvantages currently being addressed? Evaluating differences in efficacy signals: are there specific indications where one approach might be more beneficial than the other? What are the differences in side effect…Read more

day: Day One PM